Study in Patients With Asthma

Dey Pharma

Status and phase: Completed; Phase 2

Conditions: Asthma

Treatments: Drug: Formoterol Fumarate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00215410

DL-055

Details and patient eligibility

About

The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

Sex: All

Ages: 5 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children with a history of asthma
• Written guardian approval

Exclusion criteria

• Current or recent asthma exacerbation, requiring hospitalization
• History of smoking
• Debilitating or systemic and/or life-threatening diseases.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind